Aripiprazole in at-risk children with symptoms of bipolar disorder
Phase of Trial: Phase III
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Aripiprazole (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 12 Jun 2012 Actual end date (1 Jun 2012) added as reported by ClincialTrials.gov.
- 12 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Dec 2011 Planned end date changed from 1 Jan 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.